Analysis of Gut Microbiota and Their Metabolic Potential in Patients with Schizophrenia Treated with Olanzapine: Results from a Six-Week Observational Prospective Cohort Study
Open accessThe DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Abstract
Accumulating evidence indicates the potential effect of microbiota on the pathogenesis and course of schizophrenia. However, the effects of olanzapine, second-generation antipsychotics, on gut microbiota have not been investigated in humans. This study aimed to analyze fecal microbiota in schizophrenia patients treated with olanzapine during six weeks of their hospital stay. After a seven-day washout from all psychotropic medications, microbiota compositions were evaluated at baseline and after six weeks of hospitalization using 16S rRNA sequencing. The study was conducted in 20 inpatients, who followed the same hospital routine and received 5–20 mg daily doses of olanzapine. Olanzapine treatment was associated with clinical improvements in all patients and significant increases in body mass index in females, but not changes in gut microbiota compositions and predicted function. The severity of symptoms at the beginning of treatment varied in accordance with the predicted metabolic activity of the bacteria. The present findings indicate that the microbiota of schizophrenia patients is highly individual and has different taxonomical (Type 1, with a predominance of Prevotella, and Type 2 with a higher abundance of Bacteroides, Blautia and Clostridium) and functional clusters, and it does not change following six weeks of olanzapine therapy; in addition, the microbiota is not associated with either the weight gain observed in women or the effectiveness of olanzapine therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the gut microbiota composition did not change after 6 weeks of treatment with olanzapine in patients with schizophrenia [191].”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [191]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data
McMurdie, P. J., & Holmes, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061217 · Cited by 21,322 · cited 1×
“2)) [41] and ComplexHeatmap [42], and custom-made scripts.”
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192 · cited 2×
“The predicted metagenomes were analyzed with HUMAnN [39] and LEfSe [40].”
MethodVSEARCH: a versatile open source tool for metagenomics
(2016) · doi:10.7717/peerj.2584 · Cited by 10,773
Complex heatmaps reveal patterns and correlations in multidimensional genomic data
Gu, Z., Eils, R., & Schlesner, M. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw313 · Cited by 10,034 · cited 2×
“2)) [41] and ComplexHeatmap [42], and custom-made scripts.”
InfluentialPredictive functional profiling of microbial communities using 16S rRNA marker gene sequences
Langille, M. G. I., Zaneveld, J., Caporaso, J. G., McDonald, D., Knights, D., Reyes, J. A., Clemente, J. C., Burkepile, D. E., Vega Thurber, R. L., Knight, R., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2676 · Cited by 9,116
Enterotypes of the human gut microbiome
MetaHIT Consortium (additional members), Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., Fernandes, G. R., Tap, J., Bruls, T., et al. (2011) · Nature · doi:10.1038/nature09944 · Cited by 7,548 · cited 1×
“[43]), and that for cluster type 2A to enterotype 1 (Figure 2d in Arumugam et al.”
Linking long-term dietary patterns with gut microbial enterotypes
Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.-Y., Keilbaugh, S. A., Bewtra, M., Knights, D., Walters, W. A., Knight, R., et al. (2011) · Science · doi:10.1126/science.1208344 · Cited by 6,513 · cited 1×
“It was shown that microbiome composition changed detectably within 24 h of initiating a high-fat/low-fiber or low-fat/high-fiber diet, but that enterotype identity remained stable during the 10-day study [73].”
BackgroundRecognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251 · cited 1×
“Although mechanisms underlying the potential effect of microbiota on the pathogenesis and course of SZ are yet to be determined, chronic inflammation [12] and altered tryptophan metabolism [13,14] have been suggested to be implicated in the pathogenesis of SZ.”
BackgroundSudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X., Kubo, C., & Koga, Y. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.063388 · Cited by 2,735
Consensus development conference on antipsychotic drugs and obesity and diabetes
American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, & North American Association for the Study of Obesity (2004) · Diabetes Care · doi:10.2337/diacare.27.2.596 · Cited by 1,554
Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes
Boehm, G., Racoosin, J. A., Laughren, T. P., & Katz, R. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.2088-a · Cited by 1,204
Metabolic Reconstruction for Metagenomic Data and Its Application to the Human Microbiome
Abubucker, S., Segata, N., Goll, J., Schubert, A. M., Izard, J., Cantarel, B. L., Rodriguez-Mueller, B., Zucker, J., Thiagarajan, M., Henrissat, B., et al. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002358 · Cited by 1,056 · cited 2×
“The KO list was submitted as input data to HUMAnN, which generated KEGG modules and KEGG pathway abundances.”
MethodFrom gut dysbiosis to altered brain function and mental illness: mechanisms and pathways
Rogers, G. B., Keating, D. J., Young, R. L., Wong, M.-L., Licinio, J., & Wesselingh, S. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.50 · Cited by 969
De Hert, M., Dekker, J. M., Wood, D., Kahl, K. G., Holt, R. I. G., & Möller, H.-J. (2009) · European Psychiatry · doi:10.1016/j.eurpsy.2009.01.005 · Cited by 951 · cited 1×
“Therefore, dietary counseling and weight management, including regular bodyweight measurements, should be implemented as soon as the OLZ therapy begins [24,25].”
BackgroundRecovery of gut microbiota of healthy adults following antibiotic exposure
Palleja, A., Mikkelsen, K. H., Forslund, S. K., Kashani, A., Allin, K. H., Nielsen, T., Hansen, T. H., Liang, S., Feng, Q., Zhang, C., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0257-9 · Cited by 875 · cited 1×
“No formal sample size calculations were employed for this analysis, but the cohort size was based on what was previously sufficient to test microbiotic changes in schizophrenia patients [67], and/or the influence of antibiotics [68] and risperidone administration [69] on gut microbiota.”
MethodPenttilä, M., Jääskeläinen, E., Hirvonen, N., Isohanni, M., & Miettunen, J. (2014) · British Journal of Psychiatry · doi:10.1192/bjp.bp.113.127753 · Cited by 716 · cited 1×
“This observation is in agreement with that in another experimental study [65].”
ResultZheng, P., Zeng, B., Liu, M., Chen, J., Pan, J., Han, Y., Liu, Y., Cheng, K., Zhou, C., Wang, H., et al. (2019) · Science Advances · doi:10.1126/sciadv.aau8317 · Cited by 704 · cited 2×
“[10] found elevated abundance of Lactobacillaceae, Halothiobacillaceae, Brucellaceae, and Micrococcineae and lowered counts of Veillonellaceae in a cohort of SZ patients; in addition, greater microbial abnormalities, lower remission rates, and poorer responses to therapy, as well as decreased microbiome α-diversity in…”
BackgroundResultVancampfort, D., Correll, C. U., Galling, B., Probst, M., De Hert, M., Ward, P. B., Rosenbaum, S., Gaughran, F., Lally, J., & Stubbs, B. (2016) · World Psychiatry · doi:10.1002/wps.20309 · Cited by 659
Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations.
Müller, N. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby024 · Cited by 648
The role of the gut microbiome in systemic inflammatory disease
Clemente, J. C., Manasson, J., & Scher, J. U. (2018) · BMJ · doi:10.1136/bmj.j5145 · Cited by 568
Branched-Chain Amino Acids and Brain Function
Fernstrom, J. D. (2005) · The Journal of Nutrition · doi:10.1093/jn/135.6.1539s · Cited by 514 · cited 1×
“Ko00290: Valine, leucine, and isoleucine biosynthesis Protein synthesis, production of energy, compartmentalization of glutamate synthesis of amine neurotransmitters, including serotonin, dopamine, and norepinephrine Branched- chain amino acids when administered to patients with tardive dyskinesia—aberration of volunt…”
BackgroundAlmost All Antipsychotics Result in Weight Gain: A Meta-Analysis
Bak, M., Fransen, A., Janssen, J., van Os, J., & Drukker, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094112 · Cited by 490
Understanding nutrition, depression and mental illnesses
Sathyanarayana Rao, T., Asha, M., Ramesh, B., & Jagannatha Rao, K. (2008) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.42391 · Cited by 408 · cited 1×
“However, the general lifestyle in patients diagnosed with SZ was found to be divergent from that observed in healthy people [72].”
ResultAfterQC: automatic filtering, trimming, error removing and quality control for fastq data
Chen, S., Huang, T., Zhou, Y., Han, Y., Xu, M., & Gu, J. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1469-3 · Cited by 366
Schwarz, E., Maukonen, J., Hyytiäinen, T., Kieseppä, T., Orešič, M., Sabunciyan, S., Mantere, O., Saarela, M., Yolken, R., & Suvisaari, J. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2017.04.017 · Cited by 333 · cited 2×
“[10] found elevated abundance of Lactobacillaceae, Halothiobacillaceae, Brucellaceae, and Micrococcineae and lowered counts of Veillonellaceae in a cohort of SZ patients; in addition, greater microbial abnormalities, lower remission rates, and poorer responses to therapy, as well as decreased microbiome α-diversity in…”
BackgroundShen, Y., Xu, J., Li, Z., Huang, Y., Yuan, Y., Wang, J., Zhang, M., Hu, S., & Liang, Y. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.01.002 · Cited by 314 · cited 1×
“[45], using the PICRUSt analysis, infer that vitamin B6 and fatty acid metabolic potential differed significantly between SZ patients and controls.”
MethodInternational trends in antipsychotic use: A study in 16 countries, 2005–2014
Hálfdánarson, Ó., Zoëga, H., Aagaard, L., Bernardo, M., Brandt, L., Fusté, A. C., Furu, K., Garuoliené, K., Hoffmann, F., Huybrechts, K. F., et al. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.07.001 · Cited by 282
Basson, B. R., Kinon, B. J., Taylor, C. C., Szymanski, K. A., Gilmore, J. A., & Tollefson, G. D. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0404 · Cited by 279
Davey, K. J., O’Mahony, S. M., Schellekens, H., O’Sullivan, O., Bienenstock, J., Cotter, P. D., Dinan, T. G., & Cryan, J. F. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2555-2 · Cited by 275 · cited 3×
“[29,30] found decreased gut microbiota diversity, increased abundance of phyla Firmicutes, and reduced Actinobacteria, Proteobacteria, and Bacteroidetes in the course of OLZ treatment in female rats.”
BackgroundCastro-Nallar, E., Bendall, M. L., Pérez-Losada, M., Sabuncyan, S., Severance, E. G., Dickerson, F. B., Schroeder, J. R., Yolken, R. H., & Crandall, K. A. (2015) · PeerJ · doi:10.7717/peerj.1140 · Cited by 268 · cited 1×
“No formal sample size calculations were employed for this analysis, but the cohort size was based on what was previously sufficient to test microbiotic changes in schizophrenia patients [67], and/or the influence of antibiotics [68] and risperidone administration [69] on gut microbiota.”
MethodMiller, C. L., Llenos, I. C., Dulay, J. R., & Weis, S. (2006) · Brain Research · doi:10.1016/j.brainres.2005.12.056 · Cited by 242 · cited 1×
“Although mechanisms underlying the potential effect of microbiota on the pathogenesis and course of SZ are yet to be determined, chronic inflammation [12] and altered tryptophan metabolism [13,14] have been suggested to be implicated in the pathogenesis of SZ.”
BackgroundDavey, K. J., Cotter, P. D., O'Sullivan, O., Crispie, F., Dinan, T. G., Cryan, J. F., & O'Mahony, S. M. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.83 · Cited by 236 · cited 4×
“[29,30] found decreased gut microbiota diversity, increased abundance of phyla Firmicutes, and reduced Actinobacteria, Proteobacteria, and Bacteroidetes in the course of OLZ treatment in female rats.”
BackgroundInfluentialInteraction Between Atypical Antipsychotics and the Gut Microbiome in a Bipolar Disease Cohort
Flowers, S. A., Evans, S. J., Ward, K. M., McInnis, M. G., & Ellingrod, V. L. (2017) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1890 · Cited by 235 · cited 1×
“[32] revealed that clusters of gut microbiota were associated with pharmacological treatment in patients with bipolar disorder.”
BackgroundType 2 Diabetes Mellitus in Youth Exposed to Antipsychotics: A Systematic Review and Meta-analysis
Galling, B., Roldán, A., Nielsen, R. E., Nielsen, J., Gerhard, T., Carbon, M., Stubbs, B., Vancampfort, D., De Hert, M., Olfson, M., et al. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.2923 · Cited by 224
De Hert, M., Vancampfort, D., Correll, C. U., Mercken, V., Peuskens, J., Sweers, K., van Winkel, R., & Mitchell, A. J. (2011) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.084665 · Cited by 217
The antipsychotic olanzapine interacts with the gut microbiome to cause weight gain in mouse
Morgan, A. P., Crowley, J. J., Nonneman, R. J., Quackenbush, C. R., Miller, C. N., Ryan, A. K., Bogue, M. A., Paredes, S. H., Yourstone, S., Carroll, I. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115225 · Cited by 197 · cited 5×
“[31] observed that weight gain depended on gut microbiota, and specific bacteria were responsible for weight gain.”
BackgroundInfluentialBahr, S. M., Tyler, B. C., Wooldridge, N., Butcher, B. D., Burns, T. L., Teesch, L. M., Oltman, C. L., Azcarate-Peril, M. A., Kirby, J. R., & Calarge, C. A. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.135 · Cited by 197 · cited 1×
“No formal sample size calculations were employed for this analysis, but the cohort size was based on what was previously sufficient to test microbiotic changes in schizophrenia patients [67], and/or the influence of antibiotics [68] and risperidone administration [69] on gut microbiota.”
MethodWeight gain and antipsychotics: a drug safety review
Musil, R., Obermeier, M., Russ, P., & Hamerle, M. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.974549 · Cited by 187
Hormonal and Metabolic Effects of Olanzapine and Clozapine Related to Body Weight in Rodents
Albaugh, V. L., Henry, C. R., Bello, N. T., Hajnal, A., Lynch, S. L., Halle, B., & Lynch, C. J. (2006) · Obesity · doi:10.1038/oby.2006.6 · Cited by 181
Waclawiková, B., & El Aidy, S. (2018) · Pharmaceuticals · doi:10.3390/ph11030063 · Cited by 172
Pérez-Iglesias, R., Martínez-García, O., Pardo-Garcia, G., Amado, J. A., Garcia-Unzueta, M. T., Tabares-Seisdedos, R., & Crespo-Facorro, B. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001053 · Cited by 133 · cited 2×
“(3) Weight gain at the beginning of OLZ treatment is very important because it determines the further development of cardiometabolic risk factors [22,23,66].”
BackgroundKao, A. C.-C., Spitzer, S., Anthony, D. C., Lennox, B., & Burnet, P. W. J. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0116-8 · Cited by 128 · cited 2×
“As mentioned above, OLZ causes weight gain in female rats [29,44] and mice [31].”
BackgroundSkonieczna-Żydecka, K., Łoniewski, I., Misera, A., Stachowska, E., Maciejewska, D., Marlicz, W., & Galling, B. (2019) · Psychopharmacology · doi:10.1007/s00213-018-5102-6 · Cited by 98 · cited 1×
“Therefore, further experimental studies should pay more attention to this issue [70,71], although an invasive way of sampling intestine biological material remains difficult and holds several ethical concerns.”
BackgroundKynurenine pathway in psychosis: evidence of increased tryptophan degradation
Barry, S., Clarke, G., Scully, P., & Dinan, T. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108089583 · Cited by 96 · cited 1×
“Although mechanisms underlying the potential effect of microbiota on the pathogenesis and course of SZ are yet to be determined, chronic inflammation [12] and altered tryptophan metabolism [13,14] have been suggested to be implicated in the pathogenesis of SZ.”
BackgroundAbnormalities in the tricarboxylic acid (TCA) cycle in the brains of schizophrenia patients
Bubber, P., Hartounian, V., Gibson, G. E., & Blass, J. P. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.10.007 · Cited by 94 · cited 1×
“Ko00020: Citrate cycle (TCA cycle) TCA: Normal energy metabolism of the brain Abnormalities in energy metabolism were found to play a role in SZ pathophysiology [56]”
BackgroundFolate supplementation in schizophrenia: A possible role for MTHFR genotype
Hill, M. B., Shannahan, K., Jasinski, S., Macklin, E. A., Raeke, L. H., Roffman, J. L., & GOFF, D. C. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2010.12.006 · Cited by 93
Purves-Tyson, T. D., Owens, S. J., Rothmond, D. A., Halliday, G. M., Double, K. L., Stevens, J., McCrossin, T., & Shannon Weickert, C. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.257 · Cited by 80
Polyunsaturated Fatty Acid Concentration Predicts Myelin Integrity in Early-Phase Psychosis
Peters, B. D., Machielsen, M. W. J., Hoen, W. P., Caan, M. W. A., Malhotra, A. K., Szeszko, P. R., Duran, M., Olabarriaga, S. D., & de Haan, L. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs089 · Cited by 79 · cited 1×
“Ko00061: Fatty acid biosynthesis Component of membranes and myelination process mediator Lipolysis and β-oxidation were found to be upregulated in SZ, as a result of insufficient brain energy supply [60,61]”
BackgroundSerum fatty acid patterns in patients with schizophrenia: a targeted metabonomics study
Yang, X., Sun, L., Zhao, A., Hu, X., Qing, Y., Jiang, J., Yang, C., Xu, T., Wang, P., Liu, J., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.152 · Cited by 78 · cited 1×
“Ko00061: Fatty acid biosynthesis Component of membranes and myelination process mediator Lipolysis and β-oxidation were found to be upregulated in SZ, as a result of insufficient brain energy supply [60,61]”
BackgroundRisk of weight gain for specific antipsychotic drugs: a meta-analysis
Spertus, J., Horvitz-Lennon, M., Abing, H., & Normand, S.-L. (2018) · npj Schizophrenia · doi:10.1038/s41537-018-0053-9 · Cited by 77 · cited 1×
“(3) Weight gain at the beginning of OLZ treatment is very important because it determines the further development of cardiometabolic risk factors [22,23,66].”
BackgroundEfficacy of the Branched-Chain Amino Acids in the Treatment of Tardive Dyskinesia in Men
Richardson, M. A., Bevans, M. L., Read, L. L., Chao, H. M., Clelland, J. D., Suckow, R. F., Maher, T. J., & Citrome, L. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.6.1117 · Cited by 74
Liu, M., Zhang, X., Du, X.-Y., Fang, Z., Liu, Z., Xu, Y., Zheng, P., Xu, X., Cheng, P.-F., Huang, T., et al. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0540-y · Cited by 72 · cited 1×
“Ko00030: Pentose phosphate pathway Formation of NADPH for biosynthetic processes, cellular redox balance, and synthesis of ribose Pentose phosphate pathway-related molecules in schizophrenia were found to be increased [59]”
BackgroundSerum folate levels in schizophrenia: A meta-analysis
Wang, D., Zhai, J.-X., & Liu, D. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.11.045 · Cited by 67
Leppik, L., Kriisa, K., Koido, K., Koch, K., Kajalaid, K., Haring, L., Vasar, E., & Zilmer, M. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00155 · Cited by 61
Errico, F., Nuzzo, T., Carella, M., Bertolino, A., & Usiello, A. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00559 · Cited by 57 · cited 1×
“Ko00250: Alanine (ALA), aspartate (ASP), and glutamate metabolism ALA: An agonist that binds to the glycine site of NMDA receptors and improves the positive and cognitive symptoms of patients with SZ; ASP: Binding to the agonist site of NMDARs NMDAR hypofunction in schizophrenia pathogenesis [49,50]”
BackgroundCastillo, R. I., Rojo, L. E., Henriquez-Henriquez, M., Silva, H., Maturana, A., Villar, M. J., Fuentes, M., & Gaspar, P. A. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00488 · Cited by 51
Ou, J., Xu, Y., Chen, H.-H., Fan, X., Gao, K., Wang, J., Guo, X., Wu, R., & Zhao, J. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2850-6 · Cited by 46
Ketogenic diet for schizophrenia: Nutritional approach to antipsychotic treatment
Włodarczyk, A., Wiglusz, M. S., & Cubała, W. J. (2018) · Medical Hypotheses · doi:10.1016/j.mehy.2018.06.022 · Cited by 46 · cited 1×
“Ko00072: Synthesis and degradation of ketone bodies An alternative source of energy under fasting and starving; restrictive diets prolonged intense exercise Ketones may change the ratio of GABA (glutamate in favor of GABA) to compensate GABA levels in the CNS in SZ patients [64]”
BackgroundAdjunctive Taurine in First-Episode Psychosis
O’Donnell, C. P., Allott, K., Murphy, B., Yuen, H. P., Proffitt, T., Papas, A., del Moral, J. A., Pham, T., O’Regan, M. K., Phassouliotis, C., et al. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15m10185 · Cited by 38
Marlicz, W. M., Yung, D. E., Skonieczna‐Żydecka, K., Łoniewski, I., van Hemert, S., Łoniewska, B., & Koulaouzidis, A. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1343664 · Cited by 38 · cited 1×
“Therefore, further experimental studies should pay more attention to this issue [70,71], although an invasive way of sampling intestine biological material remains difficult and holds several ethical concerns.”
BackgroundDo antipsychotics increase diabetes risk in children and adolescents?
Galling, B., & Correll, C. U. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.979150 · Cited by 37
Waclawiková, B., & Aidy, S. E. (2018) · Preprints.org · doi:10.20944/preprints201805.0404.v1 · Cited by 37
Lower folate levels in schizophrenia: A meta-analysis
Cao, B., Wang, D., Xu, M., Liu, Y., Yan, L., Wang, J., & Lu, Q. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.03.003 · Cited by 36
Identification of LPS‐inducible genes downregulated by ubiquinone in human THP‐1 monocytes
Schmelzer, C., & Döring, F. (2010) · BioFactors · doi:10.1002/biof.93 · Cited by 35 · cited 1×
“Ko00130: Ubiquinone and other terpenoids–quinone biosynthesis Ubiquinone: ATP production, mitochondrial function, and reduction of proinflammatory mediators Mitochondrial dysfunction as a part of SZ etiology [54,55]”
BackgroundDisrupted sphingolipid metabolism following acute clozapine and olanzapine administration
Weston–Green, K., Babic, I., Santis, M. D., Pan, B., Montgomery, M. K., Mitchell, T. W., Huang, X., & Nealon, J. R. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0437-1 · Cited by 35 · cited 1×
“Ko00600: Sphingolipid (SL) metabolism Formation of membrane “lipid rafts” of myelin sheaths, especially in neurons and oligodendrocytes (crucial for normal synaptic neurotransmission, axon-myelin stability, and communication/connectivity) Inflammatory, synaptic, and white matter changes that result in disconnectivity…”
BackgroundFirth, J., Rosenbaum, S., Ward, P. B., Curtis, J., Teasdale, S. B., Yung, A. R., & Sarris, J. J. (2018) · Early Intervention in Psychiatry · doi:10.1111/eip.12544 · Cited by 32
Coenzyme Q10 and neuropsychiatric and neurological disorders: relevance for schizophrenia
Maguire, Á., Hargreaves, A., & Gill, M. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2018.1556481 · Cited by 31 · cited 1×
“Ko00130: Ubiquinone and other terpenoids–quinone biosynthesis Ubiquinone: ATP production, mitochondrial function, and reduction of proinflammatory mediators Mitochondrial dysfunction as a part of SZ etiology [54,55]”
BackgroundAbnormalities in Metabolism and Hypothalamic–Pituitary–Adrenal Axis Function in Schizophrenia
Guest, P. C., Martins‐de‐Souza, D., Vanattou‐Saïfoudine, N., Harris, L. W., & Bahn, S. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-387718-5.00006-7 · Cited by 30
Guest, F. L., Martins‐de‐Souza, D., Rahmoune, H., Bahn, S., & Guest, P. C. (2012) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832012005000002 · Cited by 30
Hatano, T., Ohnuma, T., Sakai, Y., Shibata, N., Maeshima, H., Hanzawa, R., Suzuki, T., & Arai, H. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.02.014 · Cited by 26 · cited 1×
“Ko00250: Alanine (ALA), aspartate (ASP), and glutamate metabolism ALA: An agonist that binds to the glycine site of NMDA receptors and improves the positive and cognitive symptoms of patients with SZ; ASP: Binding to the agonist site of NMDARs NMDAR hypofunction in schizophrenia pathogenesis [49,50]”
BackgroundAscher‐Svanum, H., Zhao, F., Detke, H. C., Nyhuis, A. W., Lawson, A. H., Stauffer, V. L., Montgomery, W. S., Witte, M. M., & McDonnell, D. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-152 · Cited by 25 · cited 1×
“Clinical responses were defined as follows: Early responders, 30% reduction in positive and negative syndrome scale (PANNS) total score at 4 weeks; late responders, 40% reduction in PANNS total score at end-point [34]; Clinical global impression-improvement scale (CGI-I) responders, score of 3 points (much improvement…”
BackgroundEarly prediction of olanzapine-induced weight gain for schizophrenia patients
Lin, C., Lin, S., Huang, Y., Wang, F., & Huang, C. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.02.058 · Cited by 14 · cited 1×
“(3) Weight gain at the beginning of OLZ treatment is very important because it determines the further development of cardiometabolic risk factors [22,23,66].”
BackgroundFolate, vitamin B12, and negative symptoms in schizophrenia
Hussein, H., Mawella, S. A. E., & Ahmed, T. (2018) · Egyptian Journal of Psychiatry · doi:10.4103/ejpsy.ejpsy_39_17 · Cited by 7
Cited by
The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders
Socała, K., Doboszewska, U., Szopa, A., Serefko, A., Włodarczyk, M., Zielińska, A., Poleszak, E., Fichna, J., & Wlaź, P. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105840 · Cited by 857
The HPA axis dysregulation in severe mental illness: Can we shift the blame to gut microbiota?
Misiak, B., Łoniewski, I., Marlicz, W., Frydecka, D., Szulc, A., Rudzki, L., & Samochowiec, J. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109951 · Cited by 343
Self-citationMicrobiota medicine: towards clinical revolution
Gebrayel, P., Nicco, C., Al Khodor, S., Bilinski, J., Caselli, E., Comelli, E. M., Egert, M., Giaroni, C., Karpinski, T. M., Loniewski, I., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03296-9 · Cited by 276
The influence of the gut microbiota on the bioavailability of oral drugs
Zhang, X., Han, Y., Huang, W., Jin, M., & Gao, Z. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.09.013 · Cited by 242
Altered gut microbiota associated with symptom severity in schizophrenia
Li, S., Zhuo, M., Huang, X., Huang, Y., Zhou, J., Xiong, D., Li, J., Liu, Y., Pan, Z., Li, H., et al. (2020) · PeerJ · doi:10.7717/peerj.9574 · Cited by 142
Metadata
- Authors
- Pełka-Wysiecka, J., Kaczmarczyk, M., Bąba-Kubiś, A., Liśkiewicz, P., Wroński, M., Skonieczna-Żydecka, K., Marlicz, W., Misiak, B., Starzyńska, T., Kucharska-Mazur, J., Łoniewski, I., & Samochowiec, J.
- Affiliations
- Pomeranian Medical University (PL)
- Department of Human Nutrition and Metabolomics, Pomeranian Medical University in Szczecin, Broniewskiego 24, 71-460 Szczecin, Poland
- Wroclaw Medical University (PL)
- Department of Gastroenterology, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-252 Szczecin, Poland
- Department of Psychiatry, Pomeranian Medical University in Szczecin, Broniewskiego 26, 71-460 Szczecin, Poland
- Corresponding author
- Łoniewski, Igor
- ORCID
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2019-10-03
- Volume
- 8
- Issue
- 10
- Pages
- 1605
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC6832832
- OpenAlex
- W2977720542
- Cited by
- 59
- References
- 74
- Citations by year
- 2026: 6 · 2025: 3 · 2024: 8 · 2023: 10 · 2022: 9 · 2021: 11 · 2020: 10 · 2019: 1
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Narodowym Centrum Nauki (UMO-2018/31/B/NZ5/00527)
- Fundusz Stymulacji Nauki (FSN-312-05/15)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- gut microbiota, schizophrenia, olanzapine, atypical antipsychotics, fecal microbiota composition, body mass index, weight gain, Prevotella, Bacteroides, Blautia, Clostridium, symptom severity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.